Multiple genetic backgrounds of the amplified plasmodium falciparum multidrug resistance (Pfrndr1) gene and selective sweep of 184F mutation in Cambodia

Journal of Infectious Diseases

Volumn 201, Issue 10, 2010, Pages 1551-1560

  Vinayak, Sumiti ^a   Alam, Md Tauqeer ^a   Sem, Rithy ^e,f   Shah, Naman K ^b   Susanti, Augustina I ^f   Lim, Pharath ^d   Muth, Sinuon ^e   Maguire, Jason D ^f   Rogers, William O ^f   Fandeur, Thierry ^g   Barnwell, John W ^a   Escalante, Ananias A ^c   Wongsrichanalai, Chansuda ^f   Ariey, Frederick ^d   Meshnick, Steven R ^b   Udhayakumar, Venkatachalam ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b IL   (United States)

^c ARIZONA STATE UNIVERSITY   (United States)

^d INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^e National Malaria Center   (Cambodia)

^f US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

^g INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ARTESUNATE; MDR1 PROTEIN, PLASMODIUM FALCIPARUM; MEFLOQUINE; MULTIDRUG RESISTANCE PROTEIN;

ALLELE; ARTICLE; CAMBODIA; CLONING; CONTROLLED STUDY; DNA FLANKING REGION; GENE; GENE AMPLIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENE NUMBER; GENETIC ANALYSIS; HAPLOTYPE; HETEROZYGOSITY; MALARIA CONTROL; MALARIA FALCIPARUM; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PFMDR1 GENE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; WILD TYPE; ANIMAL; DRUG EFFECT; DRUG RESISTANCE; GENETICS; METABOLISM; MUTATION; PARASITOLOGY;

ANIMALS; ANTIMALARIALS; ARTEMISININS; CAMBODIA; DRUG RESISTANCE; MALARIA, FALCIPARUM; MEFLOQUINE; MICROSATELLITE REPEATS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUTATION; PLASMODIUM FALCIPARUM;

EID: 77951931562     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/651949     Document Type: Article

References (49)

1. Eyles DE, Hoo CC, Warren M, Sandosham AA. Plasmodium falciparum resistant to chloroquine in Cambodia. Am J Trop Med Hyg 1963; 12: 840-843.
2. World Health Organization. Development of South-Asia surveillance network for malaria drug resistance. Report on informal consultative meeting. Geneva, Switzerland: World Health Organization, 2002.
3. Lim P, Alker AP, Khim N, et al. Pfmdrl copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar J 2009; 8:11.
4. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 2008; 359:2619-2620.
5. WongsrichanalaiC,MeshnickSR.Decliningartesunate- mefloquineefficacyagainstfalciparummalariaontheCambodia-Thailandborder. EmergInfectDis2008;14:716-719.(Pubitemid351838633)
6. Denis MB, Tsuyuoka R, Poravuth Y, et al. Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. Trop Med lnt Health 2006;11:1360-11136
7. Vijaykadga S, Rojanawatsirivej C, Cholpol S, Phoungmanee D, Nakavej A, Wongsrichanalai C. In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop Med lnt Health 2006; 11:211-219.
8. Rogers WO, Sem R, Tero T, et al. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malar J 2009; 8:10.
9. Price RN, Uhlemann AC, Brockman A, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 2004; 364:438-1147
10. Alker AP, Lim P, Sem R, et al. Pfmdrl and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am J Trop Med Hyg 2007; 76:641-647.
11. Cowman AF, Galatis D, Thompson JK. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc Natl Acad Sci U S A 1994; 91:1143-1147.
12. PeelSA,BrightP,YountB,HandyJ,BaricRS. Astrongassociationbetweenmefloquineandhalofantrineresistanceandamplification, overexpression,andmutationintheP-glycoproteingenehomolog(pfmdr) ofPlasmodiumfalciparuminvitro.AmJTropMedHyg1994;51:648-658.(Pubitemid24378562)
13. Wilson CM, Serrano AE, Wasley A, et al. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 1989; 244:1184-1186.
14. Sidhu AB, Uhlemann AC, Valderramos SG, Valderramos JC, Krishna S, Fidock DA. Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J Infect Dis 2006; 194:528-535.
15. Chaiyaroj SC, Buranakiti A, Angkasekwinai P, Looressuwan S, Cowman AF. Analysis of mefloquine resistance and amplification of pfmdr1 in multidrug-resistant Plasmodium falciparum isolates from Thailand. Am J Trop Med Hyg 1999; 61:780-783.
16. Wilson CM, Volkman SK, Thaithong S, et al. Amplification of pfmdr1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol Biochem Parasitol 1993; 57:151-160.
17. Pickard AL, Wongsrichanalai C, Purfield A, et al. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob Agents Chemother 2003; 47:2418-2423. (Pubitemid 36919439)
18. Price RN, Cassar C, Brockman A, et al. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob Agents Chemother 1999; 43:2943-2949.
19. Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF. Pghl modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 2000; 403:906-909.
20. Sidhu AB, Valderramos SG, Fidock DA. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol Microbiol 2005; 57:913-926.
21. Ngo T, Duraisingh M, Reed M, Hipgrave D, Biggs B, Cowman AF. Analysis of pfcrt, pfmdr1, dhfr, and dhps mutations and drug sensitivities in Plasmodium falciparum isolates from patients in Vietnam before and after treatment with artemisinin. Am J Trop Med Hyg 2003; 68:350-356.
22. Sisowath C, Stromberg J, Martensson A, et al. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J Infect Dis 2005; 191:1014-1017.
23. Martensson A, Stromberg J, Sisowath C, et al. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clin Infect Dis 2005; 41:1079-1086.
24. Sisowath C, Ferreira PE, Bustamante LY, et al. The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. Trop Med lnt Health 2007; 12:736-742.
25. Shah NK, Alker AP, Sem R, et al. Molecular surveillance for multidrugresistant Plasmodium falciparum, Cambodia. Emerg Infect Dis 2008; 14:1637-1640.
26. Socheat D, Denis MB, Fandeur T, et al. Mekong malaria. 11. Update of malaria, multi-drug resistance and economic development in the Mekong region of Southeast Asia. Southeast Asian J Trop Med Public Health 2003; 34(Suppl 4):1-102.
27. Smith JM, Haigh J. The hitch-hiking effect of a favourable gene. Genet Res 1974; 23:23-35.
28. Maiga O, Djimde AA, Hubert V, et al. A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa. J Infect Dis 2007; 196:165-172.
29. McCollum AM, Poe AC, Hamel M, et al. Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J Infect Dis 2006; 194:189-197.
30. McCollum AM, Mueller K, Villegas L, Udhayakumar V, Escalante AA. Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America. Antimicrob Agents Chemother 2007; 51:2085-2091.
31. Nair S, Williams JT, Brockman A, et al. A selective sweep driven by pyrimethamine treatment in southeast Asian malaria parasites. Mol Biol Evol 2003; 20:1526-1536. (Pubitemid 37082588)
32. Wootton JC, Feng X, Ferdig MT, et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 2002; 418: 320-323.
33. Anderson TJ, Roper C. The origins and spread of antimalarial drug resistance: lessons for policy makers. Acta Trop 2005; 94:269-280. (Pubitemid 40720332)
34. Ariey F, Fandeur T, Durand R, et al. Invasion of Africa by a single pfcrt allele of South East Asian type. Malar J 2006; 5:34.
35. Triglia T, Foote SJ, Kemp DJ, Cowman AF. Amplification of the multidrug resistance gene pfmdr1 in Plasmodium falciparum has arisen as multiple independent events. Mol Cell Biol 1991; 11:5244-5250.
36. Nair S, Nash D, Sudimack D, et al. Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites. Mol Biol Evol 2007; 24:562-573. (Pubitemid 46204388)
37. Su X, Ferdig MT, Huang Y, et al. A genetic map and recombination parameters of the human malaria parasite Plasmodium falciparum. Science 1999; 286:1351-1353.
38. Park SDE. Trypanotolerance in West African cattle and the population genetic effects of selection [PhD thesis]. Dublin, Ireland: University of Dublin, 2001.
39. Excoffier L, Laval G, Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 2005; 1:47-50.
40. BandeltHJ,ForsterP,RohlA.Median- joiningnetworksforinferringintraspecificphylogenies.MolBiolEvol1999;16:37-48. (Pubitemid29024937)
41. Khim N, Bouchier C, Ekala MT, et al. Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia. Antimicrob Agents Chemother 2005; 49:3147-3152.
42. Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol 2000; 108:13-23.
43. Dokomajilar C, Nsobya SL, Greenhouse B, Rosenthal PJ, Dorsey G. Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrob Agents Chemother 2006; 50:1893-1895.
44. Humphreys GS, Merinopoulos I, Ahmed J, et al. Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium fal- ciparum mdrl gene in Tanzanian children treated for uncomplicated malaria. Antimicrob Agents Chemother 2007; 51:991-997.
45. Duraisingh MT, Roper C, Walliker D, Warhurst DC. Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Mol Microbiol 2000; 36:955-961. (Pubitemid 30326539)
46. Pennings PS, Hermisson J. Soft sweeps II - molecular population genetics of adaptation from recurrent mutation or migration. Mol Biol Evol 2006; 23:1076-1084. (Pubitemid 43726073)
47. Preechapornkul P, Imwong M, Chotivanich K, et al. Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness. Antimicrob Agents Chemother 2009; 53:1509-1515.
48. White NJ, Pongtavornpinyo W. The de novo selection of drug-resistant malaria parasites. Proc Biol Sci 2003; 270:545-554. (Pubitemid 36308233)
49. Barnes DA, Foote SJ, Galatis D, Kemp DJ, Cowman AF. Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum. EMBO J 1992; 11:3067-3075.